111 related articles for article (PubMed ID: 38812805)
1. Provision of cervical cancer services for women living with HIV, Uganda.
Kalamya JN; DeCuir J; Alger SX; Ninsiima J; Kabanda J; Komakech P; Lubega M; Nantege G; Birabwa E; Nyombi TN; Namukanja P; Baveewo S; Ssendiwala J; Calnan J; Mwangi C; Nakawuka M; Mutungi G; Nelson LJ; Dirlikov E
Bull World Health Organ; 2024 Jun; 102(6):382-388. PubMed ID: 38812805
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
[TBL] [Abstract][Full Text] [Related]
3. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda.
Nyabigambo A; Mayega RW; Ginindza TG
Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623195
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
[TBL] [Abstract][Full Text] [Related]
6. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
Mitchell SM; Pedersen HN; Eng Stime E; Sekikubo M; Moses E; Mwesigwa D; Biryabarema C; Christilaw J; Byamugisha JK; Money DM; Ogilvie GS
BMC Womens Health; 2017 Jan; 17(1):4. PubMed ID: 28086933
[TBL] [Abstract][Full Text] [Related]
7. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus-based cervical precancer screening with visual inspection with acetic acid triage to achieve same-day treatments among women living with human immunodeficiency virus infection: test-of-concept study in Ibadan, Nigeria.
Awolude OA; Oyerinde SO; Ayeni AO; Adewole IF
Pan Afr Med J; 2021; 40():48. PubMed ID: 34795828
[TBL] [Abstract][Full Text] [Related]
9. Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
Kirabira J; Kayondo M; Bawakanya SM; Nsubuga EJ; Yarine F; Namuli A; Namugumya R; Natulinda CH; Atwine R; Birungi A; Lugobe HM; Tibaijuka L; Kisombo D; Jjuuko M; Agaba DC; Saturday P; Atupele SM; Tumusiime M; Migisha R; Kajabwangu R
BMC Womens Health; 2024 Apr; 24(1):266. PubMed ID: 38678278
[TBL] [Abstract][Full Text] [Related]
10. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
[TBL] [Abstract][Full Text] [Related]
11. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries.
Joseph J; Demke O; Ameyan L; Bitilinyu-Bango J; Bourgoin B; Diop M; Guèye B; Kama J; Lubega M; Madzima B; Maparo T; Mhizha T; Musoke A; Nabadda S; Phiri T; Tchereni T; Wiwa O; Hariharan K; Peter T; Khan S
BMJ Open; 2023 Jan; 13(1):e065074. PubMed ID: 36609331
[TBL] [Abstract][Full Text] [Related]
13. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda.
Wanyenze RK; Bwanika JB; Beyeza-Kashesya J; Mugerwa S; Arinaitwe J; Matovu JKB; Gwokyalya V; Kasozi D; Bukenya J; Makumbi F
Glob Health Action; 2017; 10(1):1380361. PubMed ID: 29035163
[TBL] [Abstract][Full Text] [Related]
14. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
15. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV.
Kahesa C; Thomsen LT; Linde DS; Mchome B; Katanga J; Swai P; Manongi R; Kjaerem M; Iftner T; Waldstrøm M; Mwaiselage J; Rasch V; Kjaer SK
Int J Cancer; 2023 Feb; 152(4):686-696. PubMed ID: 36093587
[TBL] [Abstract][Full Text] [Related]
16. Performance of Cervical Cancer Screening Techniques in HIV-Infected Women in Uganda.
Bansil P; Lim J; Byamugisha J; Kumakech E; Nakisige C; Jeronimo JA
J Low Genit Tract Dis; 2015 Jul; 19(3):215-9. PubMed ID: 25551591
[TBL] [Abstract][Full Text] [Related]
17. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
18. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Côte d'Ivoire.
Mensah K; Assoumou N; Duchesne V; Pourette D; DeBeaudrap P; Dumont A
BMC Womens Health; 2020 Jul; 20(1):155. PubMed ID: 32723350
[TBL] [Abstract][Full Text] [Related]
20. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]